The impact of HLA on long-term outcome after thymectomy for myasthenia gravis

Journal of Neuroimmunology

Volumn 88, Issue 1-2, 1998, Pages 177-181

  Machens, A ^a,b   Loliger C ^a   Pichlmeier, U ^a   Emskotter Th ^a   Busch, C ^a   Izbicki, J R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

HLA; MHC; Myasthenia gravis; Outcome; Thymectomy

Indexed keywords

HLA B8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ARTICLE; AUTOIMMUNITY; DISEASE SEVERITY; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MUSCLE STRENGTH; MYASTHENIA GRAVIS; PRIORITY JOURNAL; THYMECTOMY; TREATMENT OUTCOME;

ALLELES; HAPLOTYPES; HLA-B8 ANTIGEN; HUMANS; MYASTHENIA GRAVIS; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THYMECTOMY; TREATMENT OUTCOME;

EID: 0345294447     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00120-9     Document Type: Article

References (19)

1. Berrih-Aknin, S., Morel, E., Raimond, F. et al., 1987. The role of the thymus in myasthenia gravis: Immunohistological and immunological studies in 115 cases. Ann. New York Acad. Sci. 505, 50-70.
2. Busch, C., Machens, A., Pichlmeier, U., Emskötter, Th., Izbicki, J.R., 1996. Long-term outcome and quality of life after thymectomy for myasthenia gravis. Ann. Surg. 224, 225-232.
3. Christadoss, P., 1989. Immunogenetics of experimental autoimmune myasthenia gravis. Crit. Rev. Immunol. 9, 247-278.
4. Christadoss, P., Lindstrom, J., Munro, S., Talal, N., 1985. Muscle acetylcholine receptor loss in murine experimental autoimmune myasthenia gravis: correlated with cellular, humoral and clinical responses. J. Neuroimmunol. 8, 29-41.
5. Degli-Esposti, M.A., Andreas, A., Christiansen, F.T., Schalke, B., Albert, E., Dawkins, R.L., 1992. An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics 35, 355-364.
6. Erlich, H., Bugawan, T., Begovich, A.B. et al., 1991. HLA DR, DQ and DP typing using PCR amplification and immobilized probes. Eur. J. Immunogenetics 18, 33-35.
7. Jaretzki, A., Penn, A.S., Younger, D.S., 1988. 'Maximal' thymectomy for myasthenia gravis. J. Thorac. Cardiovasc. Surg. 95, 747-757.
8. Kuks, J.B.M., Lems, S.P.M., Oosterhuis, H.J.G.H., 1992. HLA type is not indicative for the effect of thymectomy in myasthenia gravis. J. Neuroimmunol. 36, 217-224.
9. Lee, J.-H., Lias, M., Deng, C.-T. et al., 1994. A one-step monoclonal antibody typing procedure that simplifies HLA class I and II typing. Tissue Antigens 44, 34-42.
10. Marsh, S.G., 1995. Nomenclature for factors of the HLA system, update March 1995. WHO Nomenclature Committee for factors of the HLA system. Tissue Antigens 45, 365-366.
11. Osserman, K.E., 1958. Myasthenia gravis. Grune and Stratton, New York, pp. 79-86.
12. Rowland, L.P., 1991. Diseases of chemical transmission at the nerve-muscle synapse: myasthenia gravis. In: Kandel, E.R., Schwartz, J.H., Jessell, T.M. (Eds.), Principles of Neural Science. Appelton and Lange, 3rd edn., Norwalk, CT, pp. 235-243.
13. Spuler, S., Sarropoulos, A., Marx, A., Hohlfeld, R., Wekerle, H., 1996. Thymoma-associated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice. Am. J. Pathol. 148, 1359-1365.
14. Spurkland, A., Gilhus, E., Rønningen, S., Aarli, J.A., Vartdal, F., 1991. Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations. Tissue Antigens 37, 90-93.
15. Vieira, M.L., Caillat-Zucman, S., Gajdos, P., Cohen-Kaminsky, S., Casteur, A., Bach, J.F., 1993. Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis. J. Neuroimmunol. 47, 115-122.
16. Wekerle, H., Hohlfeld, R., Ketelsen, U.P., Kalden, J.R., Kalies, I., 1981. Thymic myogenesis, T-lymphocytes, and the pathogenesis of myasthenia gravis. Ann. New York Acad. Sci. 377, 455-476.
17. Wu, B., Deng, C., Goluszko, E., Christadoss, P., 1997. Tolerance to a dominant T-cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis. J. Immunol. 159, 3016-3023.
18. Zhang, G.X., Ma, C.G., Xiao, B.G., Bakhiet, M., Link, H., Olsson, T., 1995. Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats. Eur. J. Immunol. 25, 1191-1198.
19. Zhang, G.X., Xiao, B.G., Bakhiet, M. et al., 1996. Both CD4+ and CD8+ T-cells are essential to induce experimental autoimmune myasthenia gravis. J. Exp. Med. 184, 349-356.